N-terminal probrain natriuretic peptide is a stronger predictor of cardiovascular mortality than c-reactive protein and albumin excretion rate in elderly patients with type 2 diabetes: The casale monferrato population-based study

Diabetes Care

Volumn 36, Issue 9, 2013, Pages 2677-2682

  Bruno, Graziella ^a   Landi, Andrea ^a   Barutta, Federica ^a   Ghezzo, Giuseppe ^b   Baldin, Claudio ^b   Spadafora, Laura ^a   Schimmenti, Andrea ^a   Prinzis, Tania ^a   Perin, Paolo Cavallo ^a   Gruden, Gabriella ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b Ospedale S Spirito Casale Monferrato   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; URIC ACID;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; EXCRETION; FEMALE; GERIATRIC PATIENT; GLUCOSE BLOOD LEVEL; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POPULATION RESEARCH; PREDICTIVE VALUE; PROSPECTIVE STUDY; SEX DIFFERENCE; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES;

EID: 84885058344     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-0353     Document Type: Article

References (20)

1. Ventura HO, Silver MA. Natriuretic peptides as markers of cardiovascular risk: the story continues. Mayo Clin Proc 2011;86: 1143-1145
2. Dunlay SM, Gerber Y, Weston SA, Killian JM, Redfield MM, Roger VL. Prognostic value of biomarkers in heart failure: application of novel methods in the community. Circ Heart Fail 2009;2: 393-400
3. Groenning BA, Nilsson JC, Sondergaard L, et al. Detection of left ventricular enlargement and impaired systolic function with plasma N-terminal pro brain natriuretic peptide concentrations. Am Heart J 2002;143: 923-929
4. Blankenberg S, Zeller T, Saarela O, et al.; MORGAM Project. Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project. Circulation 2010;121: 2388-2397
5. Wang TJ, Larson MG, Levy D, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004;350: 655-663
6. Di Angelantonio E, Chowdhury R, Sarwar N, et al. B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies. Circulation 2009;120: 2177-2187
7. Tarnow L, Hildebrandt P, Hansen BV, Borch-Johnsen K, Parving HH. Plasma N-terminal pro-brain natriuretic peptide as an independent predictor of mortality in diabetic nephropathy. Diabetologia 2005; 48: 149-155
8. Tarnow L, Gall MA, Hansen BV, Hovind P, Parving HH. Plasma N-terminal pro- B-type natriuretic peptide andmortality in type 2 diabetes. Diabetologia 2006;49: 2256-2262
9. Clodi M, Resl M, Neuhold S, et al. A comparison of NT-proBNP and albuminuria for predicting cardiac events in patients with diabetes mellitus. Eur J Prev Cardiol 2012;19: 944-951
10. Huelsmann M, Neuhold S, Strunk G, et al. NT-proBNP has a high negative predictive value to rule-out short-term cardiovascular events in patients with diabetes mellitus. Eur Heart J 2008;29: 2259-2264
11. Bruno G, Fornengo P, Novelli G, et al. C-reactive protein and 5-year survival in type 2 diabetes: the Casale Monferrato Study. Diabetes 2009;58: 926-933
12. Sattar N, Hingorani AD. C-reactive protein and prognosis in diabetes: getting to the heart of the matter. Diabetes 2009;58: 798-799
13. Bruno G, Merletti F, Bargero G, et al. Changes over time in the prevalence and quality of care of type 2 diabetes in Italy: the Casale Monferrato surveys, 1988 and 2000. Nutr Metab Cardiovasc Dis 2008;18: 39-45
14. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D; Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999;130: 461-470
15. Gruden G, Barutta F, Chaturvedi N, et al. NH2-terminal probrain natriuretic peptide is associated with diabetes complications in the EURODIAB Prospective Complications Study: the role of tumor necrosis factor-a. Diabetes Care 2012;35: 1931-1936
16. Wannamethee SG, Welsh P, Lowe GD, et al. N-terminal pro-brain natriuretic Peptide is a more useful predictor of cardiovascular disease risk than C-reactive protein in older men with and without pre-existing cardiovascular disease. J Am Coll Cardiol 2011;58: 56-64
17. Gall M-A, Borch-Johnsen K, Hougaard P, Nielsen FS, Parving H-H. Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes 1995;44: 1303-1309
18. Kroon MH, van den Hurk K, Alssema M, et al. Prospective associations of B-type natriuretic peptide with markers of left ventricular function in individuals with and without type 2 diabetes: an 8-year follow-up of the Hoorn Study. Diabetes Care 2012;35: 2510-2514
19. Roselló-Lletí E, Calabuig JR, Morillas P, et al. Variability of NT-proBNP and its relationship with inflammatory status in patients with stable essential hypertension: a 2-year follow-up study. PLoS ONE 2012;7:e31189
20. Kannel WB. Coronary heart disease risk factors in the elderly. AmJ Geriatr Cardiol 2002;11: 101-107